Epidiolex and Aimovig drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Epidiolex (cannabidiol) and Aimovig (erenumab-aooe). Common drug interactions include sleep apnoea syndrome among females and blood glucose decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Epidiolex and Aimovig. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Epidiolex?

Epidiolex has active ingredients of cannabidiol. eHealthMe is studying from 18,763 Epidiolex users. Check the latest studies of Epidiolex.

What is Aimovig?

Aimovig has active ingredients of erenumab-aooe. eHealthMe is studying from 49,930 Aimovig users. Check the latest studies of Aimovig.

On Jul, 16, 2026

12 people who take Epidiolex and Aimovig together, and have interactions are studied.

Epidiolex and Aimovig drug interactions.

What are the common drug interactions of Epidiolex and Aimovig, by gender? *:

female:

Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Spinal osteoarthritis (joint cartilage loss in spine)
Suicide attempt
Vomiting
Hospitalisation
Malaise (a feeling of general discomfort or uneasiness)
Headache (pain in head)
Hepatic steatosis (fatty liver disease)
Post-traumatic stress disorder

male:

Blood glucose decreased
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Influenza
Cough
Pyrexia (fever)

What are the common drug interactions of Epidiolex and Aimovig, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Malaise (a feeling of general discomfort or uneasiness)
Suicide attempt

60+:

n/a

What are the existing conditions these people have? *

Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 3 people, 25.00%
Constipation: 3 people, 25.00%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 16.67%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 16.67%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 16.67%
Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 1 person, 8.33%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 8.33%
Partial Seizures (seizures which affect only a part of the brain at onset): 1 person, 8.33%
Idiopathic Generalised Epilepsy (epileptic disorders that are believed to have a strong underlying genetic basis): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Epidiolex and Aimovig?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously